(DWNI) Deutsche Wohnen SE - Overview
Stock: Rental Units, Condominium Sales, Development Projects, Energy Supply
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.18% |
| Yield on Cost 5y | 0.10% |
| Yield CAGR 5y | -55.61% |
| Payout Consistency | 68.9% |
| Payout Ratio | 1.0% |
| Risk 5d forecast | |
|---|---|
| Volatility | 26.9% |
| Relative Tail Risk | -8.83% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.61 |
| Alpha | -14.69 |
| Character TTM | |
|---|---|
| Beta | -0.117 |
| Beta Downside | -0.060 |
| Drawdowns 3y | |
|---|---|
| Max DD | 30.49% |
| CAGR/Max DD | -0.05 |
Description: DWNI Deutsche Wohnen SE January 07, 2026
Deutsche Wohnen SE (XETRA:DWNI) is a German residential real-estate company that develops, lets, manages and sells apartments and single-family homes. It operates through four segments: Rental (property management and value-enhancing services), Value-Add (core leasing plus ancillary services such as multimedia and energy supply), Recurring Sales (sale of condominiums and houses) and Development (new-build projects). The firm, founded in 1863 and headquartered in Berlin, is a subsidiary of Vonovia SE, Europe’s largest landlord.
Key recent metrics (FY 2023) show a portfolio occupancy of roughly 95 % and a weighted average rental yield of about 3.5 %, delivering net operating income of €1.2 billion. The company’s dividend payout ratio hovered near 70 % with a trailing dividend yield of ~5 %, while net debt stood at €7.8 billion, giving a debt-to-EBITDA leverage of ~3.2×.
Sector-wide drivers that materially affect DWNI’s outlook include Germany’s persistent housing shortage (≈ 1.2 million units needed), low home-ownership rates (~45 % of households), and the European Central Bank’s monetary-policy stance, which influences financing costs and rent-price dynamics. Regulatory trends-particularly rent-control caps in major cities-add a layer of policy risk that can compress yields in high-demand markets.
For a deeper dive into DWNI’s valuation metrics and scenario analysis, you might explore the company’s profile on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income: -708.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA 1.61 > 1.0 |
| NWC/Revenue: -10.62% < 20% (prev -145.9%; Δ 135.3% < -1%) |
| CFO/TA 0.04 > 3% & CFO 979.8m > Net Income -708.9m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 0.94 > 1.5 & < 3 |
| Outstanding Shares: last quarter (396.7m) vs 12m ago -0.42% < -2% |
| Gross Margin: 33.52% > 18% (prev 0.40%; Δ 3312 % > 0.5%) |
| Asset Turnover: 4.85% > 50% (prev 3.41%; Δ 1.44% > 0%) |
| Interest Coverage Ratio: -2.83 > 6 (EBITDA TTM -121.1m / Interest Expense TTM 194.8m) |
Altman Z'' 1.59
| A: -0.01 (Total Current Assets 2.27b - Total Current Liabilities 2.41b) / Total Assets 26.17b |
| B: 0.32 (Retained Earnings 8.39b / Total Assets 26.17b) |
| C: -0.02 (EBIT TTM -550.9m / Avg Total Assets 26.40b) |
| D: 0.69 (Book Value of Equity 8.79b / Total Liabilities 12.83b) |
| Altman-Z'' Score: 1.59 = BB |
Beneish M 0.93
| DSRI: 0.99 (Receivables 39.5m/28.2m, Revenue 1.28b/908.9m) |
| GMI: 1.18 (GM 33.52% / 39.65%) |
| AQI: 7.02 (AQ_t 0.91 / AQ_t-1 0.13) |
| SGI: 1.41 (Revenue 1.28b / 908.9m) |
| TATA: -0.06 (NI -708.9m - CFO 979.8m) / TA 26.17b) |
| Beneish M-Score: 0.93 (Cap -4..+1) = D |
What is the price of DWNI shares?
Over the past week, the price has changed by +2.39%, over one month by +2.88%, over three months by +2.14% and over the past year by -12.83%.
Is DWNI a buy, sell or hold?
What are the forecasts/targets for the DWNI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 25.2 | 17.3% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 21.1 | -1.5% |
DWNI Fundamental Data Overview February 03, 2026
P/E Forward = 13.1752
P/S = 4.1756
P/B = 0.6474
P/EG = 2.93
Revenue TTM = 1.28b EUR
EBIT TTM = -550.9m EUR
EBITDA TTM = -121.1m EUR
Long Term Debt = 6.44b EUR (from longTermDebt, last quarter)
Short Term Debt = 10.0m EUR (from shortTermDebt, last quarter)
Debt = 86.4m EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = -202.9m EUR (from netDebt column, last quarter)
Enterprise Value = 8.11b EUR (8.32b + Debt 86.4m - CCE 289.3m)
Interest Coverage Ratio = -2.83 (Ebit TTM -550.9m / Interest Expense TTM 194.8m)
EV/FCF = 8.28x (Enterprise Value 8.11b / FCF TTM 979.8m)
FCF Yield = 12.08% (FCF TTM 979.8m / Enterprise Value 8.11b)
FCF Margin = 76.47% (FCF TTM 979.8m / Revenue TTM 1.28b)
Net Margin = -55.32% (Net Income TTM -708.9m / Revenue TTM 1.28b)
Gross Margin = 33.52% ((Revenue TTM 1.28b - Cost of Revenue TTM 851.9m) / Revenue TTM)
Gross Margin QoQ = 58.30% (prev 66.15%)
Tobins Q-Ratio = 0.31 (Enterprise Value 8.11b / Total Assets 26.17b)
Interest Expense / Debt = 50.81% (Interest Expense 43.9m / Debt 86.4m)
Taxrate = 25.0% (EU avg default 25%)
NOPAT = -413.2m (EBIT -550.9m * (1 - 25.00%)) [loss with tax shield]
Current Ratio = 0.94 (Total Current Assets 2.27b / Total Current Liabilities 2.41b)
Debt / Equity = 0.01 (Debt 86.4m / totalStockholderEquity, last quarter 12.97b)
Debt / EBITDA = 1.68 (negative EBITDA) (Net Debt -202.9m / EBITDA -121.1m)
Debt / FCF = -0.21 (Net Debt -202.9m / FCF TTM 979.8m)
Total Stockholder Equity = 13.20b (last 4 quarters mean from totalStockholderEquity)
RoA = -2.69% (Net Income -708.9m / Total Assets 26.17b)
RoE = -5.37% (Net Income TTM -708.9m / Total Stockholder Equity 13.20b)
RoCE = -2.81% (EBIT -550.9m / Capital Employed (Equity 13.20b + L.T.Debt 6.44b))
RoIC = -2.60% (negative operating profit) (NOPAT -413.2m / Invested Capital 15.88b)
WACC = 5.42% (E(8.32b)/V(8.40b) * Re(5.48%) + (debt cost/tax rate unavailable))
Discount Rate = 5.48% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 17.51%
[DCF Debug] Terminal Value 87.56% ; FCFF base≈815.2m ; Y1≈931.8m ; Y5≈1.29b
Fair Price DCF = 96.01 (EV 37.91b - Net Debt -202.9m = Equity 38.11b / Shares 396.9m; r=5.90% [WACC]; 5y FCF grow 16.73% → 2.90% )
EPS Correlation: -67.16 | EPS CAGR: -4.74% | SUE: 0.0 | # QB: 0
Revenue Correlation: -16.48 | Revenue CAGR: -1.51% | SUE: 1.10 | # QB: 5
EPS next Year (2026-12-31): EPS=2.12 | Chg30d=+0.000 | Revisions Net=-1 | Growth EPS=+84.7% | Growth Revenue=+0.0%